Presence of neural cell adhesion molecule on human embryonic and brain tumours K Development and maintenance of tissue organization in complex organisms has long been suspected to involve altered cell surface interactions between adjacent cells. Similarly, the process of tumour metastasis undoubtedly requires the expression of appropriate attachment sites for the embedding and subsequent proliferation of secondary turnours. Exciting developments in molecular cell biology are opening up new avenues for the study of both of these phenomena. The past few years have seen the identification of a whole array of glycoproteins which are involved in cell-ccll and cell-substrate adhesion.
One of the best characterized cell adhesion molecules is the neural cell adhesion molecule (N-CAM) [ 11. We became interested in this glycoprotein when we showed that monoclonal antibody UJ13A [ 2 ] , an antibody which has found extensive use in cancer medicine. recognizes N-CAM. This has led t o the investigation of N-CAM expression in human embryonic and brain tumours to assess whether lack or abnormal expression contributes t o tumour pathology and metastasis. In addition, identification of specific N-CAM isoforms associated with various tumours may allow construction of appropriate probes for differential diagnosis of tumours. Here, we briefly outline the expression of N-CAM in normal tissues and review the available data on its expression in various tumours.
Introdirction to N-C'A M
N-CAMS are a family of closely related cell surface glycoproteins believed t o mediate cell-cell interactions via a homophilic binding site in a Ca"4ndependent manner. The glycoproteins are coded for by a single gene located on chromosome 1 lq23 in humans. At least 19 exons have been described in the chicken and by extrapolation it is presumed that there are a similar number of genes in the human. Various species of N-CAM proteins have been identified which are believed t o arise through alternative splicing of mRNA and differential usage of multiple polyadenylation sites [ 3 ] .
The glycoproteins undergo a variety of post-translational modifications such as sulphation, phosphorylation and glycosylation [4] . A particular feature of the protein is the presence of long chains of polysialic acid residues linked by a2-8 linkages [S]. The polysialylation and expression of N-CAM is spatially and temporally controlled.
In the chicken, mRNA size classes of 7.4, 6.7 and 4.2 kb have been identified, whereas in the mouse and human, 7.4, 6.7, 5.2, 4.3 and 2.9 kb species are present. The 7.4 kb and 6.7 kb transcripts have been most clearly shown to code for N-CAM-180 and N-CAM-140, resepctively. In addition, a secreted form of molecular mass 1 15 kDa has been shown to be coded for by 5.2 kb mRNA [6] . It is believed that N-CAM-120 is coded for by 5.2,4.3 and 2.9 kb transcripts. N-CAM from various sources has been cloned and sequenced. The molecule belongs to the immunoglobulin supergene family. Members of this family share a common structural domain called the immunoglobulin homology unit.
Abbreviations used: N-CAM, neural cell adhesion molecule; GPI, glycosulphosphatidylinositol; MSD, muscle-specific domain.
Five immunoglobulin-like domains have been described in N-CAM expression in nortnul tissires During embryogenesis, N-CAM is widely expressed in tissues derived from all three germ layers. These include fetal brain, fetal skeletal and cardiac muscle and fetal kidney. In the adult, N-CAM expression was thought to be restricted to tissues of the nervous system and neuro-muscular junctions, although it is now becoming clear that this is not so. In addition, N-CAM is present in adult regenerating skeletal muscle and diseased cardiac muscle. The N-CAMS in brain and skeletal muscle have been well characterized and are described in detail below.
Brain. In the mouse brain, four main isoforms of N-CAM have been described of 180, 140, 120 and 1 15 kDa (in their desialo form) [6, 71 . All four isoforms have identical Ntermini, but differ primarily in the length of the cytoplasmic tail associated with them and the type of anchorage utilized for the attachment to the plasma membrane. The two largest isoforms are transmembrane glycoproteins which differ in the length of their cytoplasmic tails, whereas the 120 kDa glycoprotein is not a transmembrane protein, but is linked t o the membrane via a glycosylphosphatidylinositol (GPI) anchor [ 11. The smallest protein is believed t o be a secreted molecule.
Recent evidence suggests that there is greater heterogeneity in N-CAM expression than previously envisaged. Short sequences, coded for by mini-exons, have been identified in N-CAM which are differentially spliced into/out of mRNA transcripts. These sequences are inserted between exons 7 and 8 and exons 12 and 13. It is believed that the splicing of these additional sequences leads to tissue-specific forms of N-CAM [8] .
In the human adult brain, we have identified a 170 kDa isoform in addition to the glycoproteins described in mouse brain. At present, we cannot rule out the possibility that the 170 kDa protein is a degradation product or a differentially glycosylated isoform. The presence of N-CAM-170 in human adult brain has also been reported by Bhat &L Silberberg [9] . Their data suggests that N-CAM-170 arises from a different primary protein product rather than from degradation or post-translational modification of the other isoforms of N-CAM. We have also examined N-CAM expression in human brain during development ( I6 weeks-30 years). The data show that the expression of N-CAM-180 decreases, whereas that of N-CAM-120 increases as development proceeds. In contrast, the expression of N-CAM-140 remains relatively unchanged. Differences in N-CAM expression in different regions of the adult brain were also observed. White matter from the cerebrum and cerebellum expressed only N-CAM-120, whereas the grey matter expressed all three isoforms.
Mirscle. Skeletal muscle myoblasts express a transmembrane isoform of 140 kDa. As these cells differentiate and fuse to form myotubes, the 140 kDa isoform is replaced by N-CAM-I 55 and N-CAM-I 25 GPI-linked isoforms [ 1 OJ.
A secreted protein of 1 15 kDa has also been described [ 6 1.
The GPI-linked proteins have been shown to contain additional sequences in their extracellular domain which is restricted to skeletal muscle N-CAM and has been termed muscle-specific domain (MSD-1 ). This sequence is the bestdescribed tissue-specific sequence associated with N-CAM. MSD-1 is comprised of three discrete exons [ 1 I ] . In addition, the protein backbone translated from these three exons are sites for 0-glycosylation [ 121. Tissue-specific sequences have also been described in chick cardiac muscle [ 131.
N-CAM [I].
Other tissices. It is becoming clear that N-CAM expression in the adult may not be as restricted as previously believed. N-CAM is present in low quantity in a number o f nonneuroectodermally derived tissues. Monoclonal antibody T-199 described by Feickert et al.
I I71 also probably recognizes N-CAM on human NK cells. 
N-( 'A M evprexsion it1 tirtnour.s
We have shown that monoclonal antibody UJ I3A. raised against human fetal brain, recognizes N-CAM [ 21. This antibody reacts with tumours of neuroectodermal origin. c.g. neuroblastoma and melanoma. In addition. the reagent reacts with rhabdomyosarcorna, Wilms' tumour, Ewing's sarcoma, small cell lung carcinoma and occasionally Ieukaemia. T h e corollary is that N-CAM is present on these tissues. Wc have undertaken a detailed study to characterize the N-CAMS present on these tumours since information in this important area of tumour biology is lacking.
Ni~rrroh/r.stotn~. Apart from the data from our laboratory. there have been only two reports regarding N-CAM expression in human neuroblastoma. Lipinski et ul. [ 2 0 ] reported the presence of N-CAM-] 80 and N-CAM-140 and their corresponding mRNA transcripts in the human neuroblastoma cell line IMR32. We have confirmed this finding and undertaken a more thorough study of N-CAM expression in human neuroblastoma cell lines. Using a human N-CA M-specific cDNA probe, Northern Blot analysis showed that in general, the 6.7 kb and 5.5 kb species were present in the human ncuroblastoma cell lines tested (exceptions were NB-I and IMR-32 line which expressed the 7.4 kb transcript as well).
T h e 140 kDa protein coded by 6.7 kb mRNA is the earliest N-CAM expressed in embryogenesis and it is therefore not surprising that the 6.7 kb mRNA is predominantly expressed in embryonic tumours such as neuroblastoma. The pattern of mRNA expression in neuroblastoma cell lines is iit variance with that seen in fetal brain. RNA transcripts of 7.4.0.7, 5.5. 4.3 and 2.9 kb were observed in fetal brain. T h e significance of this observation is unclear at present. Prcliminary studies on the protein isoforms present corroborates the abovc data. Highly sialylated N-CAMS characteristic of the embryonic form are present. This result agrees with that of Livingstone et ul. [ 2 I I who reported the presence o f polysialic ilcid chains on glycoproteins from human neurohlastoma cell lines. Although the glycoprotein carrying these polysialic acid chains was not identified, it may well be N-CAM since this is the only known glycoprotein in vertebrates that has long chains of polysialic acid attached t o it.
T h e type of linkage utilized by N-CAM in neuroblastoma cell lines is being characterized at present. In addition, N-CAM isoforms in neuroblastoma tissues are being investigated since culturing of cells in vitro may have altered N-CAM expression.
Rruiri turnours. T h e presence of N-CAM in brain tumours has been assessed in our laboratory by Western blot analysis. Differences in N-CAM isoforms present in any particular tumour were noted. Oligodendroglioma and grade II astrocytoma were shown t o express N-CAMS-180, -140 and -120. whereas medulloblastoma, juvenile astrocytoma. Schwannomas and ependymomas expressed only N-CAM-140 and N-CAM-I 20. Gliomas. on the other hand expressed N-CAM-I80 and N-CAM-120. At present, it is not clear whether small differences (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) between N-CAM from normal tissue and tumours is due to posttranslational modification or differences in the primary protein product. This is currently under investigation.
Rhubdornyosurcornus. There are no reports regarding N-CAM expression in rhabdomyosarcomas. However. data from this laboratory show that N-CAM can be expressed in this childhood tumour. Transcripts of 6.7 and 5.5 kh have been detected in some of the rhabdomyosarcoma cell lines by Northern Blot analysis. In addition, the J R I cell line expresses a highly sialylated N-CAM which on ncuraminidase treatment resolves into bands of 140 and I 2 0 kDa.
Wilms' tirmoirr. Roth et ul. 1221 have demonstrated the presence of embryonic N-CAM in Wilms' tumour by immunohistochcmistry using an antibody directed against polysialic acid. Data from our laboratory corroborate this finding. Wilms' tissues were shown to express an embryonic N-CAM which a neurarninidase treatment resolved into N-CAM-140 and N-CAM-120.
Huernopoietic cell tnulignuncies. W hile in general. leukaemias d o not react with UJ 13A, there are reports suggesting that occasionally leukaemic cell lines can react with UJ 13A and thereforc express N-CAM. In addition. fresh leukaemias d o occasionally react with UJ 13A.
In our laboratory, we have shown the presence o f N-CAM on Nalrn-I6 cell line. a pre-B acute lyrnphohlastic leukaemia cell line. A smear characteristic of embryonic N-CAM is seen in Western Blot analysis. O n neuraminidase treatment, a major band of 145 kDa and a minor band of 120 kDa were observed. This is corroborated by Northern blot analysis where 6.7 kb and 5.5 kb mRNA size classes are detected. T h e results of Lanier et ul. [ 161 also show that N-CAM is present on other cell hies, e.g. K G l a , a myeloid leukaemia cell line, which expresses a 145 kDa transmembrane isoform.
Firtiire stirdies
Although N-CAM has been shown t o be present on a number of tumours. it remains a poorly characterized molecule in these turnours. Therefore, future studies will be conducted in this area to understand whether there are any subtle alterations which could play a role in the pathology o f tumours. In addition, biological studies need t o be carried out to show whether the N-CAM from tumours is functional in cell-cell adhesion and subsequent signal transduction pathways, whatever they may be.
From a clinical point o f view, if one can show that tissuespecific forms o f N-CAM resulting from splicing of the unique sequences arc present in different tumours, it should be possible to produce highly specific probes (either oligonucleotides or antisera against the peptide sequence) for differential screening o f tumours.
We are currently exploring this possibility and havc begun a study to investigate the presence of MSD-1 in rhabdomyosarcomas using the polymerase chain reaction.
Surface modulation of cell adhesion molecules is a potential mechanism for the regulation of events contributing t o tissue morphogenesis [ I ] . A group of related cell surface glycoproteins known collectively as the neural cell adhesion molecule (N-CAM) [2] A cDNA probe from clone 15 containing only 5' untranslated sequence (bases -237 to -145) is found, by Northern blot analysis, to hybridize with transcripts for transmembrane N-CAM-140/180 kDa isoforms (6.7 and 7.2 kb) found in embryonic human brain, as well as with transcripts isolated from primary human fetal muscle cultures encoding transmembrane 140 and 180 kDa isoforms, 115 kDa secreted (5.2 kb) and 125 kDa glycosylphosphatidylinositollinked (GPI-linked) (4.3 and 2.9 kb) N-CAM species. Thus, transcripts encoding embryonic brain N-CAMS and all muscle N-CAMS contain common o r very similar 5' sequence. A lack of alternative splicing within the 5' sequence was shown by S1 nuclease protection using a singlestranded '?P-labelled cDNA probe from 15 ( -237-1 15 bases) and spanning the first two exons of the human gene. These data indicate that transcripts for all N-CAM isoforms in muscle and brain are likely to be regulated from a single transcriptional domain and confirm the constitutative utilization of common 5' sequences.
Genomic clones were isolated from a charon 35 library using a cDNA probe (clone 1 5 bases -237-1 15) encoding exons one and two of the human gene. A ffiridlll fragment o f 2 kb from clone g3, that preferentially hybridized with the 5' region of the probe (bases -237 to -145), was isolated and analysed by detailed restriction endonuclease mapping (Fig.  I ) . Sites for transcriptional initiation were determined by S 1 nuclease protection using a single-stranded probe from 83 (bases -201 3 to + 5 relative to the ATG codon) with total RNA samples from human primary muscle cultures. Two major initiation sites were identified -194 and -188 bases from the ATG codon. These two major sites of transcriptional initiation determined for human muscle RNAs confirm earlier studies 1221 for sites of initiation determined using mouse brain RNAs.
The DNA sequence flanking the first exon of the human N-CAM gene was determined by analysis o f the 2 kb ffindlll
